Hologic builds bone densitometry line

Article

Bone densitometry manufacturer Hologic has added to its holdingsin the modality by acquiring product lines from WalkerSonix andSopha Medical. The products will complement Hologic's existingQDR line of bone densitometers, the Waltham, MA, company saidlate

Bone densitometry manufacturer Hologic has added to its holdingsin the modality by acquiring product lines from WalkerSonix andSopha Medical. The products will complement Hologic's existingQDR line of bone densitometers, the Waltham, MA, company saidlate last month.

Hologic bought the ultrasound bone analyzer business of WalkerSonix,a subsidiary of Walker Magnetics Group. The company's technologyuses ultrasound instead of x-rays to measure bone density. Hologicacquired patents held by WalkerSonix, as well as the company'sUBA-575+ product line. UBA-575+ is being marketed internationally,and U.S. sales are awaiting the receipt of 510(k) clearance.

Because ultrasound bone analyzers do not produce ionizing radiation,they do not require a licensed operator and are expected to becomewidely used by office-based physicians, according to Steve Nakashige,Hologic president and COO. Most sales of Hologic's QDR line areto hospitals and large clinics.

Bone densitometry has long been a sideline to Sopha Medical'smore lucrative gamma camera business. Hologic acquired worldwiderights to bone densitometry patents held by Sopha, as well asrights to the installed base of Sopha XRA and XRA-L bone densitometers.Hologic will provide technical and applications support for thisequipment. These Sopha customers will also have the option ofupgrading to Hologic's QDR-4500 Acclaim technology, introducedas a work-in-progress at the RSNA conference (SCAN 12/28/94).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.